Cargando…

Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis

BACKGROUND: Functional dyspepsia (FD) is a functional digestive disease with limited management selection. Previous studies revealed that acupuncture therapy is effective for FD. However, because sham controls were not implemented in most clinical trials following acupuncture therapy, it is difficul...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Song, Gengqing, Huang, Yizhou, Lv, Chaolan, Wang, Ying, Wu, Dandan, Sun, Chenyu, Jing, Meng, Yu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900996/
https://www.ncbi.nlm.nih.gov/pubmed/35180148
http://dx.doi.org/10.1097/MCG.0000000000001679
_version_ 1784664253033086976
author Liu, Jie
Song, Gengqing
Huang, Yizhou
Lv, Chaolan
Wang, Ying
Wu, Dandan
Sun, Chenyu
Jing, Meng
Yu, Yue
author_facet Liu, Jie
Song, Gengqing
Huang, Yizhou
Lv, Chaolan
Wang, Ying
Wu, Dandan
Sun, Chenyu
Jing, Meng
Yu, Yue
author_sort Liu, Jie
collection PubMed
description BACKGROUND: Functional dyspepsia (FD) is a functional digestive disease with limited management selection. Previous studies revealed that acupuncture therapy is effective for FD. However, because sham controls were not implemented in most clinical trials following acupuncture therapy, it is difficult to differentiate overall treatment responses from placebo. This study aims to quantify placebo responses in clinical trials in which FD patients received sham manual acupuncture (MA) and sham electroacupuncture (EA). MATERIALS AND METHODS: Randomized controlled trials of MA and EA for FD patients were searched in PubMed, Web of Science, Cochrane Library, and Embase databases, as well as 4 Chinese language databases from inception to January 2021. RevMan 5.20 software was used for pooled analysis of symptom scores and quality of life. The symptom scores were combined using standard mean difference (SMD) or weighted mean difference (WMD) with a 95% confidence interval (CI). The quality of included studies was tested using modified Jadad scale and Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) checklist. Egger’s test, Begg’s test, and sensitivity analyses were conducted using Stata 11.0 statistical software. The protocol of this study is registered in PROSPERO as CRD42021233858. RESULTS: After screening, the current systematic review included 13 randomized controlled trials, of which 8 studies were used in the meta-analysis. Regarding subjective outcomes, the combined effect of sham MA on FD symptoms was [SMD=−0.42, 95% CI (−0.72, −0.12); P=0.005], whereas sham EA treatment was [SMD=−0.54, 95% CI (−0.81, −0.27); P<0.001]. The combined effect on FD quality of life of post-sham MA group was [SMD=−0.32, 95% CI (−0.52, −0.12); P=0.002]. With regard to objective outcomes, the combined effect of sham EA on dominant frequency was [WMD=−0.11, 95% CI (−0.30, −0.08); P=0.24], while the combined effect of sham EA on dominant power was [WMD=−3.35, 95% CI (−8.04, 1.35); P=0.16]. CONCLUSIONS: Sham MA and sham EA remarkably improve symptoms and quality of life scores of FD without influencing objective outcomes, highlighting the significance of sham controls in acupuncture therapy clinical trials.
format Online
Article
Text
id pubmed-8900996
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89009962022-03-10 Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis Liu, Jie Song, Gengqing Huang, Yizhou Lv, Chaolan Wang, Ying Wu, Dandan Sun, Chenyu Jing, Meng Yu, Yue J Clin Gastroenterol Clinical Reviews BACKGROUND: Functional dyspepsia (FD) is a functional digestive disease with limited management selection. Previous studies revealed that acupuncture therapy is effective for FD. However, because sham controls were not implemented in most clinical trials following acupuncture therapy, it is difficult to differentiate overall treatment responses from placebo. This study aims to quantify placebo responses in clinical trials in which FD patients received sham manual acupuncture (MA) and sham electroacupuncture (EA). MATERIALS AND METHODS: Randomized controlled trials of MA and EA for FD patients were searched in PubMed, Web of Science, Cochrane Library, and Embase databases, as well as 4 Chinese language databases from inception to January 2021. RevMan 5.20 software was used for pooled analysis of symptom scores and quality of life. The symptom scores were combined using standard mean difference (SMD) or weighted mean difference (WMD) with a 95% confidence interval (CI). The quality of included studies was tested using modified Jadad scale and Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) checklist. Egger’s test, Begg’s test, and sensitivity analyses were conducted using Stata 11.0 statistical software. The protocol of this study is registered in PROSPERO as CRD42021233858. RESULTS: After screening, the current systematic review included 13 randomized controlled trials, of which 8 studies were used in the meta-analysis. Regarding subjective outcomes, the combined effect of sham MA on FD symptoms was [SMD=−0.42, 95% CI (−0.72, −0.12); P=0.005], whereas sham EA treatment was [SMD=−0.54, 95% CI (−0.81, −0.27); P<0.001]. The combined effect on FD quality of life of post-sham MA group was [SMD=−0.32, 95% CI (−0.52, −0.12); P=0.002]. With regard to objective outcomes, the combined effect of sham EA on dominant frequency was [WMD=−0.11, 95% CI (−0.30, −0.08); P=0.24], while the combined effect of sham EA on dominant power was [WMD=−3.35, 95% CI (−8.04, 1.35); P=0.16]. CONCLUSIONS: Sham MA and sham EA remarkably improve symptoms and quality of life scores of FD without influencing objective outcomes, highlighting the significance of sham controls in acupuncture therapy clinical trials. Lippincott Williams & Wilkins 2022-04 2022-02-17 /pmc/articles/PMC8900996/ /pubmed/35180148 http://dx.doi.org/10.1097/MCG.0000000000001679 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Clinical Reviews
Liu, Jie
Song, Gengqing
Huang, Yizhou
Lv, Chaolan
Wang, Ying
Wu, Dandan
Sun, Chenyu
Jing, Meng
Yu, Yue
Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis
title Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis
title_full Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis
title_fullStr Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis
title_full_unstemmed Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis
title_short Placebo Response Rates in Acupuncture Therapy Trials for Functional Dyspepsia: A Systematic Review and Meta-Analysis
title_sort placebo response rates in acupuncture therapy trials for functional dyspepsia: a systematic review and meta-analysis
topic Clinical Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900996/
https://www.ncbi.nlm.nih.gov/pubmed/35180148
http://dx.doi.org/10.1097/MCG.0000000000001679
work_keys_str_mv AT liujie placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT songgengqing placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT huangyizhou placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT lvchaolan placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT wangying placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT wudandan placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT sunchenyu placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT jingmeng placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis
AT yuyue placeboresponseratesinacupuncturetherapytrialsforfunctionaldyspepsiaasystematicreviewandmetaanalysis